Comment by
scarlet1967 on Aug 22, 2023 7:16am
That will be helpful: "Part 4 (basket expansion): selected cancer type diagnosed with histologically or cytologically confirmed cancers, where TH1902 has been studied and/or showed activity (in Parts 1 to 3), that is refractory or resistant to standard therapies, and where current therapy is not considered to be providing benefit."
Comment by
scarlet1967 on Aug 22, 2023 7:38am
Again to me the interesting part is 4! They plan was to enroll 6 new(as I understand it)patients in part 3 with the lower dose followed by 6 patients in part 4 on the higher dose now it seems those final 6 patients could include patients from previous enrolled patients which could only improve the odds...
Comment by
Trogarzon on Aug 22, 2023 9:00am
So the reverse split in about one month amounts to nothing once again... a neutral event. Once again wrong move, no follow up with encouraging news, no institutional support... no plan and usual disaster as anticipated and warned againts without anyone listening overthere.
Comment by
Trogarzon on Aug 22, 2023 9:41am
Honestly,I never saw a bunch of lousy no good people like this management team and BOD... it's an insult to intelligence.
Comment by
Trogarzon on Aug 22, 2023 9:51am
This company is runned by morrons on a mission to failure. I am calling upon large shareholder to call a urgent meeting.
Comment by
juniper88 on Aug 22, 2023 7:19am
That site always had "enrolling" on it. Notice, the description doesn't even have the updated description. This site simply is not updated (I have been monitoring it). The clinicaltrials.org site was updated yesterday and it still says "Active, not recruiting"
Comment by
scarlet1967 on Aug 22, 2023 7:27am
The part 3 and 4 are are new updates todsy as of yesterday there were not there also I happen to know they were enrolling/informing patients about the trial for a while but waited until their site to get updated. The government sites get updated always after the fact.